Skip Navigation LinksHome > June 2013 - Volume 20 - Issue 6 > In vivo and in vitro demonstration of herb-drug interference...
doi: 10.1097/gme.0b013e31827b2240
Original Articles

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

Chen, Jiun-Liang MD1,2,3; Wang, Jir-You PhD4; Tsai, Yi-Fang MD5; Lin, Yi-Hsien MD, PhD6,7; Tseng, Ling-Ming MD5,8; Chang, Wen-Chi MS9; King, Kuan-Liang MD5; Chen, Wei-Shone MD, PhD10,11; Chiu, Jen-Hwey MD, PhD1,5,12; Shyr, Yi-Ming MD5

Collapse Box


Objective: In recent trends, patients with breast cancer seek integrative medical treatment when receiving either hormonal (tamoxifen [Tam]) or target (trastuzumab) therapy. Our previous in vitro studies demonstrated that the Chinese medicine Si-Wu-Tang (SWT) stimulates MCF-7 cell growth via activation of estrogen receptor α and human epidermal growth factor receptor 2 (HER2) signaling. The present study demonstrates herb-drug interference with cell proliferation in tumor-bearing mice treated with SWT and Tam in vivo and with proliferation capacity in breast cancer cells treated with SWT and trastuzumab in vitro.

Methods: To assess in vivo SWT + Tam interference, we randomly separated female MCF-7–implanted athymic nude mice into five groups, namely, vehicle (n = 11), estradiol (n = 8), SWT (n = 8), Tam (n = 11), and SWT + Tam (n = 8). All mice were killed after 21 days of treatment. Body weight, uterine weight, tumor volume, and tumor weight were measured. To assess in vitro SWT-trastuzumab interference, we cotreated BT-474 and SK-BR-3 breast cancer cells with SWT and trastuzumab. This was followed by (4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assays and cell cycle analysis to measure cell proliferation and by Western blot analysis to analyze protein expression in growth-related signal pathways.

Results: SWT reversed Tam-induced antiproliferative effects on tumor weight and tumor volume and increased estrogen receptor α and N-cadherin expression in the SWT + Tam–treated group compared with the Tam-treated group. Furthermore, SWT reversed trastuzumab-induced antiproliferative activity in HER2+ cell lines (SK-BR-3 and BT-474) through increased phosphorylation of the cell cycle regulatory protein p27(Kip1) and possibly of the antiapoptosis protein P38.

Conclusions: Based on the in vivo and in vitro demonstration of herb-drug interference in breast cancer cells, we conclude that physicians should pay more attention to such interference when treating patients with receptor-positive (estrogen receptor–positive, progesterone receptor–positive, or HER2+) breast cancers.

© 2013 by The North American Menopause Society.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.